Axon Enterprise
AXON
#539
Rank
โ‚ฌ37.42 B
Marketcap
474,33ย โ‚ฌ
Share price
0.21%
Change (1 day)
-22.01%
Change (1 year)

Axon Enterprise (AXON) - Cash on Hand

Cash on Hand as of September 2025 : โ‚ฌ2.10 Billion

According to Axon Enterprise 's latest financial reports the company has โ‚ฌ2.10 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Axon Enterprise - Cash on Hand chart (from 2001 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚ฌ0.94 B-20.65%
2023-12-31โ‚ฌ1.19 B31.46%
2022-12-31โ‚ฌ0.90 B132.28%
2021-12-31โ‚ฌ0.39 B-14.38%
2020-12-31โ‚ฌ0.45 B45.91%
2019-12-31โ‚ฌ0.31 B2.51%
2018-12-31โ‚ฌ0.30 B347.16%
2017-12-31โ‚ฌ68.31 M-19.32%
2016-12-31โ‚ฌ84.67 M-15.66%
2015-12-31โ‚ฌ0.10 B50.49%
2014-12-31โ‚ฌ66.71 M79.35%
2013-12-31โ‚ฌ37.19 M30.15%
2012-12-31โ‚ฌ28.58 M40.55%
2011-12-31โ‚ฌ20.33 M-36.63%
2010-12-31โ‚ฌ32.09 M1.04%
2009-12-31โ‚ฌ31.76 M-10.08%
2008-12-31โ‚ฌ35.32 M0.53%
2007-12-31โ‚ฌ35.13 M107.61%
2006-12-31โ‚ฌ16.92 M22.6%
2005-12-31โ‚ฌ13.8 M-41.41%
2004-12-31โ‚ฌ23.55 M86.81%
2003-12-31โ‚ฌ12.61 M268.58%
2002-12-31โ‚ฌ3.42 M-46.38%
2001-12-31โ‚ฌ6.38 M2812.69%
2000-12-31โ‚ฌ0.21 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
XBiotech
XBIT
โ‚ฌ0.12 B-93.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚ฌ25.44 M-98.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚ฌ0.84 B-59.57%๐Ÿ‡บ๐Ÿ‡ธ USA